The bonds will be issued by Biocon Biologics Global plc which is a wholly owned subsidiary of BBL and will be backed by a strong security package, the company said.
Fed officials give hints on rate decision as markets cut October rate hike odds
Fed officials tempered expectations for an October rate hike after Philip Jefferson and John Williams stressed patience and data dependence. Markets sharply reduced hike odds,